<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
Safeguard Health Enterprises
- --------------------------------------------------------------------------------
(Name of Issuer)
common stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
786444109000
- --------------------------------------------------------------------------------
(CUSIP Number)
Mia Jensen c/o The Burton Partnership, Limited Partnership
Post Office Box 4643 Jackson, Wyoming 8301
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
06/11/99
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box [ ].
Check the following box if a fee is being paid with the statement [ ].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom copies
are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
CUSIP No. 786444109000 SCHEDULE 13D Page 2 of 7 Pages
--------------------- -------- --------
- -------------------------------------------------------------------------------
(1) Names of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Donald W. Burton
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
OO
- -------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
- -------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
United States
- -------------------------------------------------------------------------------
(7) Sole Voting Power
Number of 268,200
Shares --------------------------------------------------------
Beneficially (8) Shared Voting Power
Owned by 0
Each --------------------------------------------------------
Reporting (9) Sole Dispositive Power
Person With 0
--------------------------------------------------------
(10) Shared Dispositive Power
0
- -------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
268,200
- -------------------------------------------------------------------------------
(12) Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares* [ ]
- -------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
5.6%
- -------------------------------------------------------------------------------
(14) Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE> 3
CUSIP No. 786444109000 SCHEDULE 13D Page 3 of 7 Pages
--------------------- -------- --------
- -------------------------------------------------------------------------------
(1) Names of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
The Burton Partnership, Limited Partnership
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
OO
- -------------------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
- -------------------------------------------------------------------------------
(6) Citizenship or Place of Organization
Delaware Limited Partnership
- -------------------------------------------------------------------------------
(7) Sole Voting Power
Number of 268,200
Shares --------------------------------------------------------
Beneficially (8) Shared Voting Power
Owned by 0
Each --------------------------------------------------------
Reporting (9) Sole Dispositive Power
Person With 0
--------------------------------------------------------
(10) Shared Dispositive Power
0
- -------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
268,200
- -------------------------------------------------------------------------------
(12) Check Box if the Aggregate Amount in Row (11) Excludes Certain
Shares* [ ]
- -------------------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row (11)
5.6%
- -------------------------------------------------------------------------------
(14) Type of Reporting Person*
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE> 4
CUSIP #786444109000 SCHEDULE 13D PAGE 4 of 7 PAGES
ITEM 1. SECURITY AND ISSUER
- ----------------------------
This statement relates to shares of Common Stock (the "Shares"), of
Safeguard Health Enterprises (the "Company"), having its principal executive
offices at 95 Enterprise, Aliso Viejo, California.
ITEM 2. IDENTITY AND BACKGROUND
- --------------------------------
This statement is being filed by The Burton Partnership, Limited
Partnership having its principal offices at P.O. Box 4643, Jackson, Wyoming
83001; and the general partner of The Burton Partnership, Limited Partnership,
Donald W. Burton. The principal business of The Burton Partnership, Limited
Partnership is investment in public and private stocks. The general partner's
principal occupation is an investor.
The business address of the general partner is c/o The Burton
Partnership, Limited Partnership.
During the five years prior to the date hereof, neither The Burton
Partnership, Limited Partnership, nor its general partner has been convicted in
a criminal proceeding or has been a party to a civil proceeding ending in a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
The general partner is a United States citizen.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
- ----------------------------------------------------------
The Burton Partnership, Limited Partnership acquired a total of 268,200
shares of Safeguard Health Enterprises through open market transactions during a
period beginning February 16, 1999 and ending June 30, 1999 at prices ranging
from $2.75 to 3.00 per share, for an aggregate purchase price of $751,788.
No part of the purchase price paid by The Burton Partnership, Limited
Partnership for shares was represented by funds or other consideration borrowed
or otherwise obtained for the purpose of acquiring, holding, trading or voting
shares of Safeguard Health Enterprises
ITEM 4. PURPOSE OF THE TRANSACTION
- -----------------------------------
The Burton Partnership, Limited Partnership has purchased the Shares
for investment purposes only.
a. Depending on market conditions, its continuing evaluation of the
business and prospects of Safeguard Health Enterprises and other
factors, The Burton Partnership, Limited Partnership may buy or
sell additional shares in the open market. Neither The Burton
Partnership, Limited Partnership, nor the general partner has any
present plans which relate to or would result in:
<PAGE> 5
CUSIP #786444109000 SCHEDULE 13D PAGE 5 of 7 PAGES
b. An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Safeguard Health Enterprises or any of
its subsidiaries;
c. A sale or transfer of a material amount of assets of Safeguard
Health Enterprises or any of its subsidiaries;
d. Any change in the present board of directors or management of the
issuer, including any plans or proposals to change the number of term of
directors or to fill any existing vacancies on the board;
e. Any material change in the present capitalization or dividend policy
of Safeguard Health Enterprises;
f. Any other material change in Safeguard Health Enterprises business
or corporate structure, including, but not limited to, if Safeguard Health
Enterprises is a closed-end investment company, any plans or proposals to make
any changes in its investment policy for which a vote is required by section 13
of the Investment Company Act of 1940;
g. Changes in Safeguard Health Enterprises's charter or bylaws or other
actions which may impede the acquisition of control of Safeguard Health
Enterprises by any person;
h. Causing a class of securities of Safeguard Health Enterprises to be
delisted from a national securities exchange or to cease to be authorized to be
quoted in an inter-dealer quotation system of a registered national securities
association;
i. A class of equity securities of Safeguard Health Enterprises
becoming eligible for termination of registration pursuant to Section 12(g)(4)
of the Securities Exchange Act of 1934; or
j. Any action similar to any of those enumerated above.
ITEM 5. INTEREST IN SECURITIES AND THE ISSUER
- ----------------------------------------------
By virtue of his status as general partner of The Burton Partnership,
Limited Partnership, Donald W. Burton may thus be deemed to be beneficial owner
of the 268,200 shares which The Burton Partnership, Limited Partnership owns of
record, representing 5.6% of the Company. Donald W. Burton may thus be deemed to
share with The Burton Partnership, Limited Partnership the power to direct the
voting and disposition of the shares which The Burton Partnership, Limited
Partnership own of record.
The aggregate 268,200 shares purchased by The Burton Partnership,
Limited Partnership were obtained in the following open market transactions.
<PAGE> 6
CUSIP #786444109000 SCHEDULE 13D PAGE 6 of 7 PAGES
<TABLE>
<CAPTION>
(1) (2) (3) (4) (5)
Person who
Effected Settlement Date Number of Price Per Brokerage House & How
Transaction of Transaction Shares Share Transactions was Effected
----------- -------------- ------ ----- -------------------------
<S> <C> <C> <C> <C>
General Partner 02/22/99 10,000 2.8125 J. C. Bradford & Co.
General Partner 02/22/99 5,600 2.8125 J. C. Bradford & Co.
General Partner 02/22/99 5,100 2.8125 J. C. Bradford & Co.
General Partner 02/19/99 1,700 2.8125 J. C. Bradford & Co.
General Partner 02/19/99 1,100 2.7500 J. C. Bradford & Co.
General Partner 02/23/99 600 2.8125 J. C. Bradford & Co.
General Partner 02/24/99 9,300 2.8125 J. C. Bradford & Co.
General Partner 02/26/99 2,100 2.8125 J. C. Bradford & Co.
General Partner 02/16/99 1,600 2.7500 J. C. Bradford & Co.
General Partner 02/24/99 200 2.8125 J. C. Bradford & Co.
General Partner 03/03/99 2,000 2.8125 J. C. Bradford & Co.
General Partner 03/05/99 700 2.8125 J. C. Bradford & Co.
General Partner 03/08/99 10,000 2.8125 J. C. Bradford & Co.
General Partner 03/08/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/09/99 5,000 2.8125 J. C. Bradford & Co.
General Partner 03/10/99 500 2.7500 J. C. Bradford & Co.
General Partner 03/10/99 5,000 2.8125 J. C. Bradford & Co.
General Partner 03/11/99 1,100 2.8125 J. C. Bradford & Co.
General Partner 03/12/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/15/99 37,800 2.8125 J. C. Bradford & Co.
General Partner 03/22/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/23/99 4,500 2.8125 J. C. Bradford & Co.
General Partner 03/24/99 3,000 2.8125 J. C. Bradford & Co.
General Partner 03/25/99 300 2.8125 J. C. Bradford & Co.
General Partner 03/26/99 17,900 2.8125 J. C. Bradford & Co.
General Partner 03/29/99 74,000 2.8125 J. C. Bradford & Co.
General Partner 03/29/99 30,000 2.7813 J. C. Bradford & Co.
General Partner 06/07/99 1,300 2.7500 J. C. Bradford & Co.
General Partner 06/08/99 1,800 2.7500 J. C. Bradford & Co.
General Partner 06/10/99 1,500 2.7500 J. C. Bradford & Co.
General Partner 06/11/99 3,100 2.7500 J. C. Bradford & Co.
General Partner 06/11/99 23,200 2.7500 J. C. Bradford & Co.
General Partner 06/16/99 100 2.7500 J. C. Bradford & Co.
General Partner 06/17/99 3,200 2.7500 J. C. Bradford & Co.
General Partner 06/29/99 1,000 3.0000 J. C. Bradford & Co.
General Partner 06/30/99 3,000 3.0000 J. C. Bradford & Co.
------- -------
TOTAL 268,200 751,788
</TABLE>
No other person is known to have the right to receive or the power to
direct the receipt of dividends from, or any proceeds from the sale of, the
shares beneficially owned by The Burton Partnership, Limited Partnership and the
general partner. CUSIP #786444109000 SCHEDULE 13D PAGE 7 of 7 PAGES
<PAGE> 7
CUSIP #786444109000 SCHEDULE 13D PAGE 7 of 7 PAGES
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
- ------------------------------------------------------------------------------
Except as described elsewhere herein, there are no contracts,
arrangements, understandings or relationships (legal or otherwise) among The
Burton Partnership, Limited Partnership and the general partner or between any
such person and any other person with respect to the securities, finder's fees,
joint ventures, loan or option arrangements, puts or calls, guarantees of
profits, division of profits or loss or the giving or withholding of proxies.
SIGNATURE
- ---------
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this statement is true, complete
and correct.
Dated: June 30, 1999 The Burton Partnership, Limited Partnership
By: /s/ Donald W. Burton
---------------------------------------
Donald W. Burton, General Partner
